Further gain-of-function and loss-of-function studies (Fig. 4) indicated that the effect of ID1 on cell proliferation and oxaliplatin chemoresistance was mediated by G6PD activation in HCC cells. Here, G6PD is linked to hepatocellular carcinoma.